Journal
/
Immunology and Infection
/
Quantifying Vaccine-Induced Neutralizing Antibodies in SARS-CoV-2 Variants
/
Toepassing van Ha-CoV-2-pseudovirus voor snelle kwantificering van SARS-CoV-2-varianten en neutraliserende antilichamen
JoVE Journal
Immunology and Infection
This content is Free Access.
JoVE Journal Immunology and Infection
Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies
Please note that all translations are automatically generated. Click here for the English version.

Toepassing van Ha-CoV-2-pseudovirus voor snelle kwantificering van SARS-CoV-2-varianten en neutraliserende antilichamen

Nederlands

Automatically Generated

549 Views

•

01:18 min

•

September 08, 2023

DOI:

10.3791/65793-v

DOI:
10.3791/65793-v

•

01:18 min
September 08, 2023

•

4 Views
, ,
1Center for Infectious Disease Research, School of Systems Biology,George Mason University

Explore More Videos

Ha-CoV-2 PseudovirusSARS-CoV-2 VariantsOmicron SubvariantNeutralizing AntibodiesBSL-3 FacilitiesVirus-like ParticleAlphavirus VectorPandemic SurveillanceVaccine ValidationRapid QuantificationInfectivityReporter Genes

Read Article

Cite this Article

Chilin, L., Hetrick, B., Wu, Y. Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies. J. Vis. Exp. (199), e65793, doi:10.3791/65793 (2023).

Download .ris file

Copy

Share Video

.

Copy